News and Updates

Breakthrough T1D is funding work on multiple ways to delay or prevent the onset of type 1 diabetes (T1D). This team thinks fat tissue may hold a key to this research. Kacey Prentice, Ph.D., works with other researchers in the Hotamisligil Lab at the Harvard T.H. Chan School of Public Health. There, she is helping […]

Breakthrough T1D is committed is to curing type 1 diabetes (T1D) through beta cell therapies, which is a complicated problem with myriad potential solutions. One approach Breakthrough T1D is actively pursuing is through regeneration: Targeting the islet cells in the body and encouraging them to proliferate and create insulin again. To solve this problem, Breakthrough T1D […]

Can we internally regenerate and protect beta cells, and therefore find cures for type 1 diabetes (T1D)? One scientist thinks so. Bridget Wagner, Ph.D., is a scientist at the Broad Institute, and her group’s research focuses on the chemical biology of diabetes, with the aim of identifying small molecules capable of increasing pancreatic beta cell […]

Scientists in Norway are seeking participants for a clinical trial to see if a course of anti-viral treatment may stop beta cell destruction. Pancreatic infection with some viruses, known as enteroviruses, are a likely candidate as one of the environmental causes of type 1 diabetes (T1D). The reason: Evidence of enteroviral infection has been found […]

Join us for an inside look at the collaborations and skills that researchers in Boston are using to tackle the complex task of replacing beta cells in people with type 1 diabetes (T1D). Beta cell replacement is the art and science of taking or making beta cells from outside a person’s body, and then putting […]

The work of type 1 diabetes (T1D) researchers is so compelling and full of hope. But it also is a bit shrouded in curious mystery. What goes on inside the many labs all around the world? Who are these scientists, what drives them and what gives us reason to be excited about the advances they […]

Mark Atkinson, Ph.D., a longtime Breakthrough T1D-funded researcher, is the recipient of 2019 Jacobus Prize for his research into the development of type 1 diabetes (T1D). First established in 1939, the Jacobus Prize is awarded annually by the Novo Nordisk Foundation to a distinguished international researcher to promote medical research. It is the largest international […]

ViaCyte, a beta cell replacement company long supported by Breakthrough T1D, has shown—for the first time ever—that its PEC-Direct therapy helps people with type 1 diabetes (T1D) produce insulin again. Preliminary data from ViaCyte’s clinical trial show that when pancreatic precursor cells, called “PEC-01 cells,” are implanted under the skin and properly engrafted, they are […]

To say that Halloween is ‘fun’ is an understatement! So many kids and adults look forward to this one evening of dressing up, eating as much candy as they want and partying with friends!  But Halloween can be scary in more than the obvious way for families of those newly diagnosed with type 1 diabetes […]

For 55 years, leading researchers from around the world have gathered for the annual meeting of the European Association for the Study of Diabetes (EASD). At this year’s meeting, from September 16-20 in Barcelona, Spain, more than 50 studies were presented by Breakthrough T1D researchers, funded now or in the past, working to find cures […]